LABINFEC INGLES
Tu Tienda OnLine Gratis
Injectable solutionQuali-quantitative composition for 100 ml of solution:Vitamin B6 (Pyridoxine Hydrochloride) …… ………………………………...……. 2.50 gVitamin B15 (Diisopropylamine dichloroacetate)…………………….. 2.50 gOrphenadrine citrate …………… ..… 2.00 gMagnesium aspartate dihydrate ………2.00 g(Equivalent to 150 mg of Magnesium)Excipients q.s.p. ………………… ..… 100 ml Generalities:The work of the SPC is exclusively muscular and of great effort. For this reason, the animal is constantly suffering from musculoskeletal problems, which are manifested in the form of fatigue, contracture, cramps and pain, which decrease performance.It is a powerful muscle relaxant and tonic.It acts selectively on the Central Nervous System, reducing the hyperactivity of the striated muscle, producing as a result relaxation without altering its normal tone, thus producing the vicious cycle of contracture-pain-contracture, facilitating and increasing blood supply, oxygenation and accelerating the elimination of metabolites, placing the animal in optimal conditions and in full force. Target Species:Sports or working equines not intended for human consumptionIndications of use:• Animals subjected to physical effort due to training, competition, demanding work, etc.• To shorten the recovery time, in animals that have suffered diseases, accidents, contractures, stiffness, myositis, acute muscle spasm.Dosage and Administration: Route: SLOW intravenous route.Dose: 2 ml daily every 100 k.p.v, for 3 to 5 days in a row or at the discretion of the acting veterinarian.Adverse Effects: Eventual appearance of cough, which is not important.Contraindications: It must be administered by a Veterinarian.Presentation: Containers containing 50 and 100 mlConservation: Keep at room temperature, between 15 and 25 º C, in a cool place protected from light.KEEP OUT OF THE REACH OF CHILDREN AND DOMESTIC ANIMALS.Keep in mind for shipments that the unit weight of the product is 108 gr or 3.81 oz
DESCRIPTIONNon-narcotic and non-steroidal anti-inflammatory, analgesic and antipyretic, based on Flunixin Meglumine in injectable solution.COMPOSITION:Flunixin, Meglumine: 5 g.Excipients q.s.p.: 100 ml.ACTIONFlunixin is a powerful non-narcotic analgesic with anti-inflammatory and antipyretic activity. In Veterinary Medicine it is associated with meglumine that acts as a solubilizing agent.It is used to relieve inflammation and pain associated with conditions of the musculoskeletal system and colic in horses and other conditions in pigs and cattle.It has a strong inhibitory action on the oxygenase cycle system of the inflammatory reaction, which prevents the formation of prostaglandins and thromboxanes from arachidonic acid.INDICATIONSNon-narcotic and non-steroidal anti-inflammatory, analgesic and antipyretic.Horses: inflammation of muscles, bones and/or joints: trauma, spinal pain, myalgia, arthropathies, myositis, bursitis, tendinitis. Treatment of colic and infectious or non-infectious neonatal diarrhea. Respiratory pathologies. Treatment of endotoxic shock.Cattle: Coliform mastitis, metritis, intestinal and respiratory pathologies, febrile processes in general, musculoskeletal disorders. Treatment of endotoxic shock.Swine: Support therapy in metritis-mastitis-agalaxia syndrome and gastro-intestinal pathologies. Treatment of endotoxic shock.CONTRAINDICATIONS AND WARNINGSThe intra-arterial administration of the product can cause adverse reactions (incoordination, ataxia, muscle weakness), which are fleeting and disappear quickly without the need for medication. This route of administration should be avoided.It should not be administered in conjunction with other nonsteroidal anti-inflammatory drugs. Nor should it be associated with drugs that produce renal toxicity.The safety of Flunixin when co-administered with other drugs or biologics has not been established. Therefore, if this situation occurs, the patient must be specially controlled.Treatment should not exceed 5 days in any of the species for which it is intended.Do not administer to animals younger than 3 days. Its use in pregnant females is not recommended. Do not administer in race horses during the 8 days prior to the competition.Do not mix in the same syringe with other injectable solutions.COLLATERAL DAMAGEOccasionally a slight inflammatory reaction may occur at the injection site, which resolves favorably within 48-72 hours without the need for any treatment.In intramuscular administration it is recommended to divide the dose in two points. Occasionally, after intramuscular administration in cattle, irritation may occur, which is why intravenous administration is preferable in this species.Given the characteristics of the product, the presentation of symptoms of intoxication is very unlikely.In the indicated doses no toxic effects are known. However, at a dose 5 times higher than that indicated, adverse effects may be observed.There are no specific antidotes.DOSAGECattle:Skeletal muscle conditions: 1 ml every 45 kg of live weight intramuscularly or intravenously; repeat the dose every 24 hours.Mastitis, metritis, respiratory and digestive processes: 2 ml every 45 kg of live weight intravenously.Pigs:In all cases: 2 ml every 45 kg of weight by deep intramuscular route.Treatment of mastitis metritis-agalaxy syndrome: administration should be repeated every 12 hours if symptoms persist, for 1 to 3 days.Digestive processes: repeat every 24 hours.Horses:Musculoskeletal conditions: 1 ml every 45 kg of live weight, intramuscularly or intravenously. If necessary, the treatment can be repeated 24 hours after the first application. The treatment should last 5 days.Colic laminitis, shock: 1 ml every 45 kg of live weight, intravenously. Administration should be repeated if symptoms reappear. In case of laminitis, treatment should last 3 days.Digestive and respiratory processes: 1 ml every 45 kg of live weight, intramuscularly or intravenously. Repeat every 24 hours up to 5 days.PRESENTATION50 ml vial.RESTRICTIONS OF USEThe time that must elapse between the last day of treatment and the slaughter of the animal for human consumption is 21 days in cattle and pigs.Do not administer the product to dairy cattle if the milk is intended for human consumption.The product should not be used in horses intended for human consumption.Injectable APPLICATIONKeep in mind for shipments that the unit weight of the product is 116 gr or 4.09 oz
DESCRIPTIONNon-narcotic and non-steroidal anti-inflammatory, analgesic and antipyretic, based on Flunixin Meglumine in injectable solution.COMPOSITION:Flunixin, Meglumine: 5 g.Excipients q.s.p.: 100 ml.ACTIONFlunixin is a powerful non-narcotic analgesic with anti-inflammatory and antipyretic activity. In Veterinary Medicine it is associated with meglumine that acts as a solubilizing agent.It is used to relieve inflammation and pain associated with conditions of the musculoskeletal system and colic in horses and other conditions in pigs and cattle.It has a strong inhibitory action on the oxygenase cycle system of the inflammatory reaction, which prevents the formation of prostaglandins and thromboxanes from arachidonic acid.INDICATIONSNon-narcotic and non-steroidal anti-inflammatory, analgesic and antipyretic.Horses: inflammation of muscles, bones and/or joints: trauma, spinal pain, myalgia, arthropathies, myositis, bursitis, tendinitis. Treatment of colic and infectious or non-infectious neonatal diarrhea. Respiratory pathologies. Treatment of endotoxic shock.Cattle: Coliform mastitis, metritis, intestinal and respiratory pathologies, febrile processes in general, musculoskeletal disorders. Treatment of endotoxic shock.Swine: Support therapy in metritis-mastitis-agalaxia syndrome and gastro-intestinal pathologies. Treatment of endotoxic shock.CONTRAINDICATIONS AND WARNINGSThe intra-arterial administration of the product can cause adverse reactions (incoordination, ataxia, muscle weakness), which are fleeting and disappear quickly without the need for medication. This route of administration should be avoided.It should not be administered in conjunction with other nonsteroidal anti-inflammatory drugs. Nor should it be associated with drugs that produce renal toxicity.The safety of Flunixin when co-administered with other drugs or biologics has not been established. Therefore, if this situation occurs, the patient must be specially controlled.Treatment should not exceed 5 days in any of the species for which it is intended.Do not administer to animals younger than 3 days. Its use in pregnant females is not recommended. Do not administer in race horses during the 8 days prior to the competition.Do not mix in the same syringe with other injectable solutions.COLLATERAL DAMAGEOccasionally a slight inflammatory reaction may occur at the injection site, which resolves favorably within 48-72 hours without the need for any treatment.In intramuscular administration it is recommended to divide the dose in two points. Occasionally, after intramuscular administration in cattle, irritation may occur, which is why intravenous administration is preferable in this species.Given the characteristics of the product, the presentation of symptoms of intoxication is very unlikely.In the indicated doses no toxic effects are known. However, at a dose 5 times higher than that indicated, adverse effects may be observed.There are no specific antidotes.DOSAGECattle:Skeletal muscle conditions: 1 ml every 45 kg of live weight intramuscularly or intravenously; repeat the dose every 24 hours.Mastitis, metritis, respiratory and digestive processes: 2 ml every 45 kg of live weight intravenously.Pigs:In all cases: 2 ml every 45 kg of weight by deep intramuscular route.Treatment of mastitis metritis-agalaxy syndrome: administration should be repeated every 12 hours if symptoms persist, for 1 to 3 days.Digestive processes: repeat every 24 hours.Horses:Musculoskeletal conditions: 1 ml every 45 kg of live weight, intramuscularly or intravenously. If necessary, the treatment can be repeated 24 hours after the first application. The treatment should last 5 days.Colic laminitis, shock: 1 ml every 45 kg of live weight, intravenously. Administration should be repeated if symptoms reappear. In case of laminitis, treatment should last 3 days.Digestive and respiratory processes: 1 ml every 45 kg of live weight, intramuscularly or intravenously. Repeat every 24 hours up to 5 days.PRESENTATION50 ml vial.RESTRICTIONS OF USEThe time that must elapse between the last day of treatment and the slaughter of the animal for human consumption is 21 days in cattle and pigs.Do not administer the product to dairy cattle if the milk is intended for human consumption.The product should not be used in horses intended for human consumption.Injectable APPLICATIONKeep in mind for shipments that the unit weight of the product is 460 gr or 16.22 oz
Injectable solutionNon-steroidal anti-inflammatoryVETERINARY USE50, 100 and 250 ml. COMPOSITION:Phenylbutazone…………………………..20 gExcipients q.s.p………………………..100 ml ACTIONBUTA INFEC is a powerful non-steroidal anti-inflammatory and antirheumatic based on phenylbutazone for the treatment of rheumatism in all its forms and locations.The product attacks the inflammation-pain-muscle spasm triad, eliminating inflammation and spasm, thereby eliminating pain and establishing myoarticular mobility and muscle tone.INDICATIONS:Non-steroidal anti-inflammatory for the management of musculoskeletal conditions in the horse, as well as generalized arthritis.Adjuvant treatment in inflammatory alterations and painful processes of mild or moderate intensity of the musculoskeletal system. Such as: arthritis, osteoarthritis, osteoarthritis, tendonitis, tenosynovitis, bursitis, myositis, laminitis. Acute and chronic inflammatory processes. Rheumatism of any etiology and location.DOSE, METHOD AND ROUTE OF ADMINISTRATION:It will be administered strictly IV.Horses: 1.1 ml – 2.2 ml of BUTA INFEC/100 kg. l.w./day.Equivalent 220 mg to 440 mg of Fenibutazone kg b.w./dayMaximum dose: 10 ml/horse/day and 5 ml/pony/dayEquivalent to 2000 mg kg p.v./day and 1000 mg kg p.v./dayA relatively high dose will be administered for the first 24-48 hours and then gradually decreased until the lowest dose that produces a clinical response is reached.It is advised not to administer by injection (IV) for more than 5 consecutive days.In young and very old animals readjust the dose.CONTRAINDICATIONS AND WARNINGS:Do not administer to animals with a history of hypersensitivity or allergy to non-steroidal anti-inflammatory drugs.Do not administer to animals with: gastritis or gastric or duodenal ulcer; kidney, liver, or heart disease; blood dyscrasias, coagulopathies, hemorrhages, edemas or hemoglobinuria.Do not administer to dehydrated animals.Do not administer during the first weeks of life.It is not recommended for use in animals with severe heart, liver or kidney damage, as well as with a history of blood dyscrasias or anemia.In the treatment of inflammatory conditions associated with specific infections, anti-infective therapy is required. In some chronic conditions such as chronic osteoarthritis, therapy with this drug, if it does not produce a permanent cure, may be due to advanced changes in the tissue, in which case discontinuation of treatment would sometimes cause a recurrence of symptoms. However, intermittent therapy can be extremely valuable in relieving symptoms of chronic inflammatory injury.INCOMPATIBILITIES AND INTERACTIONS:Do not administer with other analgesics, corticosteroids, barbiturates, chloramphenicol, sulfonamides, anticoagulants, anticonvulsants, hydantoin type and hypoglycemic agents.SIDE EFFECTS:Can produce:• Digestive disorders (gastritis, colic, diarrhea), jaundice, dark or tarry stools.• Depression and anorexia.• Blood dyscrasias, decreased platelet aggregation (petechiae, hemorrhages) and phlebopathies.• Hydrosaline retention (edema).• Decreased white blood cell count or relative decrease in granulocytes.At the first symptom it is advisable to stop treatment.A routine blood count is convenient to do weekly, during the first phase of therapy and every 2 weeks thereafter. . SPECIAL PRECAUTIONS FOR ITS USE:• Administer by IV route slowly and carefully, since it can cause phlebitis at the point of application.• During treatment, do not restrict water consumption and administer a diet low in protein, nitrogen and chlorides (remove salt stones).• Do not use in visceral pain of any etiology.• Periodically perform blood tests.• If no clinical response is seen within 48 hours, discontinue treatment and reconsider diagnosis.• Do not administer more than 5 consecutive days.USE DURING PREGNANCY AND LACTATION:Do not administer to pregnant or lactating females.Keep in mind for shipments that the unit weight of the product is 206 gr or 7.26 oz
DESCRIPTIONAnti-inflammatory, anti-exudative, anti-proliferative and anti-allergic, based on Dexamethasone for horses, cattle, pigs, sheep, goats, cats and dogs.COMPOSITIONDexamethasone (sodium 21 phosphate): 0.4 g.Aqueous excipient q.s.p.: 100 ml.ACTIONAnti-inflammatory, antiexudative, antiproliferative and antiallergic. Dexamethasone is a corticosteroid with a mechanism of action and intensity of effect 4 to 5 times higher than that of the same concentration of a suspension of crystalline Prednisolone.With CORTIDEX a hormonal effect and a thermodynamic effect are achieved. The hormonal action consists in the regulation of carbohydrate metabolism: it increases blood glucose, stimulates the new formation of sugars from proteins and fats, increases hepatic glucose. It has antitoxic and antiallergic action.The pharmacodynamic action consists of an intense inhibition of the mesenchymal, anti-inflammatory, antiexudative and antiproliterative reaction.INDICATIONSIn all target species, before inflammations caused by infections, allergies, trauma or other etiologies. Shock and circulatory collapse, ketosis in cattle.CONTRAINDICATIONS AND WARNINGSDo not administer to animals with bacterial diseases without concomitant antibiotic therapy, fungal or viral infections, kidney and/or liver failure, congestive heart failure, osteoporosis, bone fractures, diabetes mellitus, degenerative eye diseases or corneal ulcers, hyperadrenocorticism, animals subjected to immunological treatment.Do not administer to pregnant females during the last third of pregnancy, as it can cause premature delivery followed by dystocia, fetal death, retained placenta and metritis. Milk production in lactating animals may be temporarily decreased by administration of dexamethasone.Do not administer together with:-Antidiabetics: the hyperglycemic action of corticosteroids can counteract the antidiabetogenic effect.-Barbiturates: parenterally, they can lead to a loss of therapeutic efficacy of corticosteroids.Potassium-depleting diuretics: can lead to significant hypokalaemia with the consequent risk of cardiac and muscular pathological manifestations.-Indomethacin: administered parenterally, it can lead to an increased incidence of gastrointestinal disorders and especially peptic ulcer.-Salicylates: can lead to a decrease in plasma salicylates. In addition, the harmful effects on the gastric mucosa can be enhanced.-Antihistamines: increase the degradation of Dexamethasone.Do not administer concomitant therapy with other corticosteroids.In case of infectious or parasitic diseases, apply together with antibiotics or specific antiparasitic.Prolonged use of the recommended doses for weeks or months can give symptoms of Cushing's, and abrupt interruption of treatment leads to atrophy of the adrenal glands (Hypoadrenocorticism).Important: It is up to the veterinarian to establish an emergency therapy in the aforementioned cases contraindicated for its use. COLLATERAL DAMAGEIn cases of infections, its own symptoms such as pyrexia, lassitude and loss of appetite can be masked.Decreases organic defenses predisposing the animal more easily to microbial infections. Causes delayed wound healing.It can cause weakness of the striated muscles.In dogs and cats it can cause an increase in serum alkaline phosphatase (SAP) and serum glutamic pyruvic transaminase (SGPT) enzymes, weight loss, anorexia, diarrhea (sometimes bloody), vomiting, polydipsia and polyuria. Euphoria and some changes in the behavior of the animal with improvement in attitude have also been observed.In horses, a dose higher than 5 mg/animal can cause lethargy, which usually subsides within 24 hours. In some cases, it can cause laminitis.DOSAGEAdministration by intramuscular, subcutaneous or intravenous route.Cattle, sheep, goats, pigs and horses: 0.005-0.02 ml per kg of body weight, single dose.Canine: 0.0125-0.05 ml per kg of live weight in a single dose.Feline: 0.025-0.075 ml per kg of body weight, single dose.Intra-articular administration:Large animals: 0.5-2.5 ml.Small animals: 0.125-1.25 ml, repeat if necessary, every 24-48 hours, for a maximum period of 5 days.SPECIESPRESENTATION.50 and 100 ml.RESTRICTIONS OF USEDo not administer to horses whose meat is intended for human consumption.For meat the waiting time is 5 days, for milk it is 3 days.APPLICATIONLocal injectable, InjectableKeep in mind for shipments that the unit weight of the product is 202 gr or 7.12 oz
DESCRIPTIONAnti-inflammatory, anti-exudative, anti-proliferative and anti-allergic, based on Dexamethasone for horses, cattle, pigs, sheep, goats, cats and dogs.COMPOSITIONDexamethasone (sodium 21 phosphate): 0.4 g.Aqueous excipient q.s.p.: 100 ml.ACTIONAnti-inflammatory, antiexudative, antiproliferative and antiallergic. Dexamethasone is a corticosteroid with a mechanism of action and intensity of effect 4 to 5 times higher than that of the same concentration of a suspension of crystalline Prednisolone.With CORTIDEX a hormonal effect and a thermodynamic effect are achieved. The hormonal action consists in the regulation of carbohydrate metabolism: it increases blood glucose, stimulates the new formation of sugars from proteins and fats, increases hepatic glucose. It has antitoxic and antiallergic action.The pharmacodynamic action consists of an intense inhibition of the mesenchymal, anti-inflammatory, antiexudative and antiproliterative reaction.INDICATIONSIn all target species, before inflammations caused by infections, allergies, trauma or other etiologies. Shock and circulatory collapse, ketosis in cattle.CONTRAINDICATIONS AND WARNINGSDo not administer to animals with bacterial diseases without concomitant antibiotic therapy, fungal or viral infections, kidney and/or liver failure, congestive heart failure, osteoporosis, bone fractures, diabetes mellitus, degenerative eye diseases or corneal ulcers, hyperadrenocorticism, animals subjected to immunological treatment.Do not administer to pregnant females during the last third of pregnancy, as it can cause premature delivery followed by dystocia, fetal death, retained placenta and metritis. Milk production in lactating animals may be temporarily decreased by administration of dexamethasone.Do not administer together with:-Antidiabetics: the hyperglycemic action of corticosteroids can counteract the antidiabetogenic effect.-Barbiturates: parenterally, they can lead to a loss of therapeutic efficacy of corticosteroids.Potassium-depleting diuretics: can lead to significant hypokalaemia with the consequent risk of cardiac and muscular pathological manifestations.-Indomethacin: administered parenterally, it can lead to an increased incidence of gastrointestinal disorders and especially peptic ulcer.-Salicylates: can lead to a decrease in plasma salicylates. In addition, the harmful effects on the gastric mucosa can be enhanced.-Antihistamines: increase the degradation of Dexamethasone.Do not administer concomitant therapy with other corticosteroids.In case of infectious or parasitic diseases, apply together with antibiotics or specific antiparasitic.Prolonged use of the recommended doses for weeks or months can give symptoms of Cushing's, and abrupt interruption of treatment leads to atrophy of the adrenal glands (Hypoadrenocorticism).Important: It is up to the veterinarian to establish an emergency therapy in the aforementioned cases contraindicated for its use. COLLATERAL DAMAGEIn cases of infections, its own symptoms such as pyrexia, lassitude and loss of appetite can be masked.Decreases organic defenses predisposing the animal more easily to microbial infections. Causes delayed wound healing.It can cause weakness of the striated muscles.In dogs and cats it can cause an increase in serum alkaline phosphatase (SAP) and serum glutamic pyruvic transaminase (SGPT) enzymes, weight loss, anorexia, diarrhea (sometimes bloody), vomiting, polydipsia and polyuria. Euphoria and some changes in the behavior of the animal with improvement in attitude have also been observed.In horses, a dose higher than 5 mg/animal can cause lethargy, which usually subsides within 24 hours. In some cases, it can cause laminitis.DOSAGEAdministration by intramuscular, subcutaneous or intravenous route.Cattle, sheep, goats, pigs and horses: 0.005-0.02 ml per kg of body weight, single dose.Canine: 0.0125-0.05 ml per kg of live weight in a single dose.Feline: 0.025-0.075 ml per kg of body weight, single dose.Intra-articular administration:Large animals: 0.5-2.5 ml.Small animals: 0.125-1.25 ml, repeat if necessary, every 24-48 hours, for a maximum period of 5 days.SPECIESPRESENTATION.50 and 100 ml.RESTRICTIONS OF USEDo not administer to horses whose meat is intended for human consumption.For meat the waiting time is 5 days, for milk it is 3 days.APPLICATIONLocal injectable, InjectableKeep in mind for shipments that the unit weight of the product is 111 gr or 3.91
Analgesic. Antipyretic. Antispasmodic. Anti-inflammatory.Composition:Each 100 ml contains:Sodium dipyrone…………… 50.0 gExcipients q.s.p.………. 100mlGeneralitiesMetamizole is a prodrug, which spontaneously decomposes after administration to structurally related pyrazolone compounds. Apart from its analgesic effect, the drug is an antipyretic and spasmolytic agent.Sodium dipyrone (metamizole) has a mode of action similar to that of other NSAIDs and involves the inhibition of prostaglandin synthesis through cyclooxygenase. In contrast to other NSAIDs, metamizole also has antispasmodic activity.Indications of use:DIPYRONE 50% is indicated to prevent and combat the sensation of colic pain of various etiologies and spastic conditions of the abdominal organs, acute and chronic arthritis, rheumatic conditions of the muscles and joints, neuritis, neuralgia, tendovaginitis. Esophageal-pharyngeal obstruction due to foreign bodies and other diseases with a high risk of fever and/or inflammatory processes.Target species Horses and canines.Dosage, mode and form of administrationHorses: 5 ml / 100 Kg p/v (equivalent to 2.5 g of Dipyrone sodium for each100 kg live weight). Via: IM/IVIn case of intramuscular administration it is recommended to divide the total doseprescribed.Dogs: 0.5 ml /10 kg (equivalent to 250 mg of dipyrone sodium for each10kg). Via: IM/IVInterval between doses: The dose can be repeated every 12 hours, in case ofbe necessary.Treatment duration:The duration of treatment is at the discretion of the acting veterinarian.Contraindications– Although dipyrone is a very mild NSAID, these types of drugs should be avoided or very carefully monitored in animals with liver disease, kidney disease, or GI problems. Therapy should be stopped at the first sign of any adverse reaction such as ulcers, depression, decreased plasma protein, increased creatinine, anemia, or leukopenia.– Dipyrone should be given slowly when used IV. Rapid administration can cause seizures.– Dipyrone should be used with caution in old or debilitated animals, particularly those with heart disease.– Dipyrone should not be used in animals with a history of blood or bone marrow abnormalities.Side effects– The most common side effect for dipyrone is injection site reactions.– Prolonged use of dipyrone may cause bone marrow suppression (leukopenia, agranulocytosis). Animals receiving prolonged courses of dipyrone should be followed up with regular CBCs.Interactions– Should not be used simultaneously with chlorpromazine due to potentially severe hypothermia.– It should not be used together with phenylbutazone or barbiturates.OverdoseThe mode of administration of the product makes intoxication due to overdose unlikely.In an emergency, it is suggested that standard overdose procedures be followed. Control seizures. Monitor gastrointestinal bleeding.Form of presentation:Injectable solution in amber glass bottles containing: 100 ml.Storage:Store in its original container, between 15 to 25ºC in a cool place and protected from light.Keep in mind for shipments that the unit weight of the product is 215 gr or 7.58 oz
nonsteroidal anti-inflammatoryInjectable solutionComposition:Each 100 mL contains:Tolfenamic acid 8.0 gExcipients q.s.pIndications:Highly active non-steroidal anti-inflammatory, for the treatment of acute or chronic processes. With analgesic and antipyretic properties. Complementary treatment of inflammatory infectious processes.Mastitis, osteoarticular pathologies, respiratory inflammatory processes, MMA syndrome in pigs, treatment of post-surgical pain, etc.Animal species to which it is intended:Cattle and pigs, canine and feline equines.Withdrawal period and precautions:Meat: Cattle: 11 days, Pigs: 3 days.Milk: 0 daysContraindicated in cases of heart or liver disease and in cases of bleeding digestive ulcers. Do not administer to animals with hypersensitivity to the active ingredient. Administer according to the recommended dose. Do not administer together with other NSAIDs. In pigs, only apply intramuscularly, use with caution in animals younger than 6 weeks. It is recommended not to apply more than 20 ml per injection point.Route of administration:Intramuscular, applying the asepsis measures corresponding to the administration of injectables.In pigs, only apply deep intramuscular route in the neck.DoseIt is recommended 1ml every 20 kg of weight (2 mg7kg of live weight). If used together with antibiotics in infectious processes, which do not improve within 48 hours, a second dose may be necessary after this period.In very acute processes, a double dose or the recommended dose can be applied for 2 consecutive days.More than 5 consecutive applications are not recommended.Horses: 2.5 ml / 100 Kg p/v (equivalent to 2 mg of Tolfenamic Acid pereach kg of live weight). Route: Deep intramuscular (IM)Canines:For acute pain: 0.5 ml /10 kg (equivalent to 4 mg of Tolfenamic Acid per kg). Route: Intramuscular or subcutaneous (IM / SC), for 3 to 5 days.For chronic pain: 0.5 ml /10 kg (equivalent to 4 mg of Tolfenamic Acid per kg). Route: Intramuscular or subcutaneous (IM / SC), for 3 to 5 days per weekFelines:Indicated for acute pain / inflammation in cats.For acute pain: 0.5 ml /10 kg (equivalent to 4 mg of Tolfenamic Acid per kg). Route: Intramuscular or subcutaneous (IM / SC), for 3 to 5 days.Interval between doses: Daily dose.Treatment duration:Horses: 2 to 3 days.Canines: For acute pain: for 3 to 5 days.For chronic pain: for 3 to 5 days per week.Felines: For acute pain: for 3 to 5 days.In all cases, the duration of treatment is at the discretion of the acting veterinarian.Keep in mind for shipments that the unit weight of the product is 122 gr or 4.3 Click here to see the video
Sale of veterinary products for animals, especially horses, pigs, cattle, etc.
Texto de Descripcion
2023 Sistema PXW - Pedidos Por WhatsApp ©